US-based drug discovery and development service company Crown Bioscience and Horizon Discovery have entered into a two year collaboration agreement to provide combined solutions for in vivo model development. Under the partnership, ...
Vernalis has reached a research milestone as part of the oncology drug discovery alliance with French pharmaceutical company, Servier. Under the drug discovery program, Vernalis will receive a payment of €0.5m from Servier on ...
Tags: drug discovery platforms, oncology drug discovery, undisclosed oncology